Quantcast

Latest Lennox–Gastaut syndrome Stories

2009-11-02 06:00:00

Harnessing the power of professional athletes, who wear helmets in their careers, to help erase the stigma associated with epilepsy. CHICAGO and NEW YORK, Nov. 2 /PRNewswire-USNewswire/ -- November is Epilepsy Awareness Month. The Lennox Gastaut Syndrome Foundation (LGSF) and the American Epilepsy Outreach Foundation (AEOF) has joined with Eisai Pharmaceuticals and Lundbeck Pharmaceuticals to co-host the 1st Annual Helmets for Hope(TM) Campaign. The Helmets for Hope(TM) is an awareness...

2009-03-27 14:04:00

PRINCETON, N.J., March 27 /PRNewswire/ -- Zydus Pharmaceuticals announced today that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available for immediate shipment. Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures. It is also...

2008-11-20 19:35:58

The U.S. Food and Drug Administration has approved a new drug, rufinamide -- marketed as Banzel -- to treat severe epilepsy. The drug is to be used as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome. This approval offers another treatment option for patients who suffer from these debilitating, severe seizures, Dr. Russell Katz of the FDA's Center for Drug Evaluation and Research said Thursday in a statement. Lennox-Gastaut syndrome is a severe form of epilepsy...

2008-07-25 09:01:18

Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, has announced that the FDA has granted pediatric exclusivity for Topomax. The grant was based on studies submitted in response to a written request by the FDA to investigate the use of Topomax in pediatric patients aged one to 24 months with partial onset seizures. In addition to granting pediatric exclusivity, the FDA is continuing its review of the application to determine the safety and efficacy of Topomax in...

2008-07-24 18:00:23

TITUSVILLE, N.J., July 24 /PRNewswire/ -- Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for TOPAMAX(R) (topiramate), based on studies submitted in response to a Written Request by the FDA to investigate the use of TOPAMAX in pediatric patients aged 1 to 24 months with partial onset seizures. In addition to granting pediatric exclusivity, the FDA is...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.